Figure 4.
![Anti-BKV T-cell activity and clinical response in patients treated with BKV-specific VSTs for active BKV infection. (A) Anti-BKV antigen (viral capsid protein 1 [VP1], large T [LgT]) T-cell response of the BKV-specific VST products as detected by IFN-γ ELISpot assay. Anti-BKV antigen T-cell response and BKV viral load (copies per milliliter) in the recipient PB post-VST infusion for patient P4 treated with BKV infection (B) and timing of concomitant standard antiviral treatment. BKV, BK virus; PCR, polymerase chain reaction; SFU, spot forming units.](https://ash.silverchair-cdn.com/ash/content_public/journal/bloodadvances/7/10/10.1182_bloodadvances.2022008219/1/blooda_adv-2022-008219-gr4.jpeg?Expires=1750244751&Signature=ZJLW1e9zld~V0fvCN3kTEoMdYyMDvK1wGMHIN7t6EaK947RrBCZPWoHO2s89n7a4XZ4wvAQF9Enx74MzR7Dq0rIj8lF8ozZa6W1RR4CPh7oovwgGizamL4o9K9dyce5wjRdMUsEfPiEvJIxRX7EF6cL4WZA6vl6WN5D6fCejQvGRTow8hQZzTHtx5W0ebZYVQAjKlRAVXuqI5YbFosYDK0LkzZ~qF71PKZrFl0oYWNeZQZ0IT4WaP9Nd6njLP4hsxFAPXpP6T7aOTmiuvpURlh-QOPP4XE4hg2sQU09WB1JeyKU8FQxmL1~o3tKCHJAD~-ke-0Ft0mrJVjkRzEzCgA__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Anti-BKV T-cell activity and clinical response in patients treated with BKV-specific VSTs for active BKV infection. (A) Anti-BKV antigen (viral capsid protein 1 [VP1], large T [LgT]) T-cell response of the BKV-specific VST products as detected by IFN-γ ELISpot assay. Anti-BKV antigen T-cell response and BKV viral load (copies per milliliter) in the recipient PB post-VST infusion for patient P4 treated with BKV infection (B) and timing of concomitant standard antiviral treatment. BKV, BK virus; PCR, polymerase chain reaction; SFU, spot forming units.
